ACC Reps sticking or bailing?













It's over. We've been on borrowed time for the past 6 mos. at least the shit didn't hit the fan before thanksgiving. Let's hope they wait until January before the axe falls.
 












It's over. We've been on borrowed time for the past 6 mos. at least the shit didn't hit the fan before thanksgiving. Let's hope they wait until January before the axe falls.

All Joking aside, you guys should be good until March or April from what I heard ! Also other positions are available in other areas throughout company for SOME qualified individuals
:eek:hr4u:eek:
 
























My take is that they don't give a shit who is leaving or not. As they keep us in the dark, good people are leaving. They don't care if they have to re-hire and get good talent. Def lay-offs for sure-just don't know who or how many. No openings either in this division-says something
 












They don't give a shit, will watch and see what the attrition totals are, and go from there.
This entire division could easily be cut with little consequence, you don't need sales people to promote generics, just a few order takers and contract people. We are toast people, just a matter of time. Be happy if it's later vs sooner.
 


















So you don't think ANyone will be left for biosims?

We have even less information on biosims than Dyloject. It seems impossible for someone on the field sales level to make accurate prediction around those products. Would it really be a shock to not have a biosim approved until 2016? Would you really need a sales rep for these products as opposed to a combination of an MSL/clinical educator and contracting?

I think it is a stretch to think many ACCS field personnel will be retained for biosims
 






We have even less information on biosims than Dyloject. It seems impossible for someone on the field sales level to make accurate prediction around those products. Would it really be a shock to not have a biosim approved until 2016? Would you really need a sales rep for these products as opposed to a combination of an MSL/clinical educator and contracting?

I think it is a stretch to think many ACCS field personnel will be retained for biosims

Totally agree, it will be all contracting and it will be very competitive since every company is jumping into that market.
 






Maybe they can't bridge to Biosims but they will need a salesforce. It's going to take much to convince docs to use and injectibles if you have sold them require much with regards to reimbursement and convincing
 












Maybe they can't bridge to Biosims but they will need a salesforce. It's going to take much to convince docs to use and injectibles if you have sold them require much with regards to reimbursement and convincing

They might need a few reps but no where near what we have now. In the current hospital climate of trying to save as much money as possible, it won't be difficult to convince them to use these products, it will be a matter of who they buy it from and it will be extremely competitive which is where contracting comes into play.